Observational study reveals increased mycoplasma pneumoniae incidence in children post-COVID-19, indicating ongoing surveillance is vital.
Key Points
Mycoplasma pneumoniae infections significantly increased in pediatric patients post-COVID-19, highlighting a shift in respiratory infection dynamics.
The incidence of mycoplasma pneumoniae among respiratory infections rose from 3.2% in 2019 to 6.1% in 2024, indicating a marked resurgence post-pandemic.
Retrospective observational study analyzed clinical and laboratory data of 303 hospitalized children with mycoplasma pneumoniae infection from 2017 to 2024.
Despite increased incidence of infections, clinical severity including need for respiratory support remained consistent, pointing to stable outcomes.